XML 92 R66.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Government Contracts - Additional Information (Detail) | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
Feb. 28, 2018 USD ($) | Dec. 31, 2017 USD ($) Option | Apr. 30, 2017 USD ($) | Feb. 28, 2017 USD ($) | Sep. 30, 2016 USD ($) | Jun. 30, 2016 USD ($) Option | Dec. 31, 2017 USD ($) | Sep. 30, 2017 USD ($) | Jun. 30, 2017 USD ($) | Mar. 31, 2017 USD ($) | Dec. 31, 2016 USD ($) | Dec. 31, 2017 USD ($) Option | Dec. 31, 2016 USD ($) | Mar. 12, 2018 USD ($)
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Grant revenue |  |  |  |  |  |  | $ 993,000 | $ 597,000 | $ 249,000 | $ 140,000 | $ 335,000 | $ 1,979,000 | $ 335,000 |
Revenue included in other receivables |  | $ 1,011,000 |  |  |  |  | 1,011,000 |  |  |  | 304,000 | 1,011,000 | 304,000 |
U.S. Department of Defense [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract term |  |  |  |  | 2 years |  |  |  |  |  |  |  |  |
Potential grant amount awarded |  |  |  |  | $ 1,500,000 |  |  |  |  |  |  |  |  |
Grant revenue |  |  |  |  |  |  |  |  |  |  |  | 700,000 | 300,000 |
Revenue included in other receivables |  | 100,000 |  |  |  |  | 100,000 |  |  |  | $ 300,000 | 100,000 | $ 300,000 |
Niaid [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract term |  |  |  | 12 months |  |  |  |  |  |  |  |  |  |
Grant revenue |  |  |  |  |  |  |  |  |  |  |  | 400,000 |  |
Niaid [Member] | Spero Cantab [Member] | Cantab Anti Infectives Ltd. [Member] | Cantab Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum potential funding from government contract |  |  |  |  |  | $ 5,700,000 |  |  |  |  |  |  |  |
Number of option period for funding from government contract | Option |  |  |  |  |  | 3 |  |  |  |  |  |  |  |
Maximum received fund |  | $ 1,300,000 |  |  |  |  |  |  |  |  |  | $ 1,300,000 |  |
Niaid [Member] | Spero Cantab [Member] | Cantab Anti Infectives Ltd. [Member] | Cantab Agreements [Member] | First Option [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of option period for funding from government contract | Option |  | 2 |  |  |  |  |  |  |  |  |  | 2 |  |
Committed amount from government contract |  | $ 5,100,000 |  |  |  |  |  |  |  |  |  | $ 5,100,000 |  |
Niaid [Member] | Maximum [Member] | Other Receivables [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue invoiced but unpaid |  | 100,000 |  |  |  |  | 100,000 |  |  |  |  | 100,000 |  |
Niaid [Member] | Base Period Contracts [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Potential grant amount awarded |  |  |  | $ 600,000 |  |  |  |  |  |  |  |  |  |
Niaid [Member] | Option Period Contracts [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Potential grant amount awarded |  |  |  | $ 400,000 |  |  |  |  |  |  |  |  |  |
Niaid [Member] | Option Period Contracts [Member] | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract term | 12 months |  |  |  |  |  |  |  |  |  |  |  |  |
Potential grant amount exercised | $ 400,000 |  |  |  |  |  |  |  |  |  |  |  |  |
CARB-X [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract term |  |  | 12 months |  |  |  |  |  |  |  |  |  |  |
Potential grant amount awarded |  |  | $ 1,500,000 |  |  |  |  |  |  |  |  |  |  |
Grant revenue |  |  |  |  |  |  |  |  |  |  |  | 900,000 |  |
Revenue included in other receivables |  | $ 700,000 |  |  |  |  | $ 700,000 |  |  |  |  | $ 700,000 |  |
Potential grant amount exercised |  |  | $ 0 |  |  |  |  |  |  |  |  |  |  |
CARB-X [Member] | Subsequent Event [Member] | First Option [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Government Contracts [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Potential grant amount awarded |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 400,000

X
- Definition Contract term. + References No definition available. + Details
Name: | spro_ContractTerm
Namespace Prefix: | spro_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Government Contracts [Line Items] + References No definition available. + Details
Name: | spro_GovernmentContractsLineItems
Namespace Prefix: | spro_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum potential funding from government contract + References No definition available. + Details
Name: | spro_MaximumPotentialFundingFromGovernmentContract
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum received fund amount. + References No definition available. + Details
Name: | spro_MaximumReceivedFundAmount
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of option period for funding from government contract. + References No definition available. + Details
Name: | spro_NumberOfOptionPeriodForFundingFromGovernmentContract
Namespace Prefix: | spro_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential grant amount awarded. + References No definition available. + Details
Name: | spro_PotentialGrantAmountAwarded
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Potential grant amount exercised. + References No definition available. + Details
Name: | spro_PotentialGrantAmountExercised
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Proceeds from government contract + References No definition available. + Details
Name: | spro_ProceedsFromGovernmentContract
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Revenue invoiced but unpaid. + References No definition available. + Details
Name: | spro_RevenueInvoicedButUnpaid
Namespace Prefix: | spro_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount due from parties in nontrade transactions, classified as other. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherReceivables
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_RevenueFromGrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=spro_USDepartmentOfDefenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=spro_NiaidMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidatedEntitiesAxis=spro_SperoCantabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=spro_CantabAntiInfectivesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ShareRepurchaseProgramAxis=spro_CantabAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OptionIndexedToIssuersEquityTypeAxis=spro_FirstOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=spro_OtherReceivablesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=spro_BasePeriodContractsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=spro_OptionPeriodContractsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=spro_CARBXMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |